London: After the first dose of astraZeneca Or pfizer According to a study published in The, second-dose vaccines of Moderna or Novavax jabs produce stronger immune responses against Covid-19. Knife magazine. a team led by researchers University of Oxford The UK study of 1,070 participants found no safety concerns were raised.
The study supports the flexible use of these vaccines in the primary immunization programme, which is important to help these vaccines be rapidly deployed, especially in low- and middle-income countries where vaccine supplies may be inconsistent. “Thanks to studies like these, we are now getting a more complete picture of how different vaccines can be used together in the same vaccine schedule,” Mathew said. snap at Oxford University. “Encouragingly, all of these schedules generated antibody concentrations above the two doses licensed and effective oxford-azi Schedule,” Snape said. When it comes to cellular immunity, the researchers said, the first dose of the AZ shot produced a particularly strong response after the first dose of the AZ shot than any other study vaccine. In addition, a significantly higher number of short-term vaccine reactions were reported in volunteers who received a second dose of Moderna compared to those who received two doses of AZ or Pfizer.
The study supports the flexible use of these vaccines in the primary immunization programme, which is important to help these vaccines be rapidly deployed, especially in low- and middle-income countries where vaccine supplies may be inconsistent. “Thanks to studies like these, we are now getting a more complete picture of how different vaccines can be used together in the same vaccine schedule,” Mathew said. snap at Oxford University. “Encouragingly, all of these schedules generated antibody concentrations above the two doses licensed and effective oxford-azi Schedule,” Snape said. When it comes to cellular immunity, the researchers said, the first dose of the AZ shot produced a particularly strong response after the first dose of the AZ shot than any other study vaccine. In addition, a significantly higher number of short-term vaccine reactions were reported in volunteers who received a second dose of Moderna compared to those who received two doses of AZ or Pfizer.
,